Canada is poised to launch a national portal that will provide a near real-time snapshot of the evolving COVID-19 pandemic across Canada, including the detection and spread of variants of concern. It will also establish the national data infrastructure Canada needs to track future pandemics.
Organization: McGill University
The Short Report – April 7, 2021: VC investment hits $4.4 billion in 2020, Ontario’s rise as a hub for autonomous vehicles, Gairdner Awards recognize biomedical research, and more
VC investment in Canada hit its second highest level last year, Canada’s annual Gairdner awards announced, Quebec SMEs benefit from a $9 million e-commerce boost, Ontario invests in autonomous vehicles, and more.
Q&A: Dr. Richard Gold on why open science partnerships could reverse declining research productivity
Spending on scientific research has been rising for the last 50 years while, at the same time, researcher productivity has been dropping. That’s what Dr. Richard Gold, law professor and Director of the Centre for Intellectual Property Policy at McGill University, argues in a new paper that positions open science partnerships as a potential solution.
The Short Report – March 24, 2021: Genome Canada creates data portal to address COVID-19 variants, Suncor invests US$25M in carbon capture tech, a national agriculture network, and more.
Genome Canada launches a SARS-CoV-2 data portal to consolidate variants of concern data in one place, Calgary’s Suncor Energy invests in carbon capture technology to offset GHG emissions, Government of Canada invests $185 million in an agricultural program to share best practices for storing carbon, and more.
The Short Report – Feb 17, 2021: NSERC supports Huawei research collaboration, ALS research gets a boost, Ottawa invests in SMEs transitioning to clean tech, and more.
Natural Sciences and Engineering Research Council collaborates with the Canadian arm of Huawei Technologies, Canadian and international teams receive funding to accelerate ALS research, SDTC supports SMEs across Canada in their adoption of clean technology, an unexpected donation spurs Northern Ontario School of Medicine to address health inequities in marginalized populations, and more.
The Short Report – Jan 6, 2021: National Research Council has a new president, drones deliver PPE to remote communities, a hydrogen strategy for Canada, and more
NAIT researchers are collecting and analyzing microplastics in a first-of-its-kind study, Tim Hockey has been recruited to lead digital transformation in Ontario for the next three years, Dr. Ted Hewitt is reappointed president of SSHRC, and the IRPP calls for a roadmap to link training opportunities to skills and jobs.
COVID science has created a sea of bad data, conflicting results and exaggerated headlines. We can do better.
The COVID-19 pandemic has placed a spotlight on the biomedical research process and amplified the adverse ramifications of poor public communication. We need to do better.
CFI awards $28 million for COVID-19 research infrastructure
The Canada Foundation of Innovation has announced the first awards from program that pivoted earlier this year to support scientific infrastructure related to studying COVID-19.
The Short Report – Oct. 14, 2020: CIHR signs MOU to support Inuit-led health research, Health Canada accepts rolling submission for a COVID-19 vaccine candidate, and more
Facedrive’s TraceSCAN technology garners interest among companies globally; Canada’s National Digital Research Infrastructure Strategy has its first researcher council, and a new consortium takes shape to accelerate the commercialization of quantum computing.
Human genome editing is not safe for clinical use, but nations must prepare: Report
A highly anticipated report says heritable genome editing, using tools like CRISPR to create edits that can be passed down to future generations, is not yet safe enough for clinical use. But it also provides specific guidance on how nations should prepare for the eventual use of CRISPR or other gene editing tools, defining a translational pathway from research to the clinic.